Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F74ML
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,443
Award facts
- Contract value 100% obligated
- $10,442.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded February 4, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Ondansetron ODT 4 mg tablets in 30-count quantities with a ceiling value of $10,442.88 and firm fixed pricing. The award is non-competitive, representing a task order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The performance location is listed as Conshohocken, Pennsylvania, the company's corporate headquarters, with an ultimate completion date of February 5, 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal military and veteran healthcare systems. As a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain, the company maintains a comprehensive portfolio delivering prescription medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and other government healthcare institutions. The Ondansetron ODT tablets procured under this order are anti-nausea medications commonly used in military and federal healthcare settings for chemotherapy patients and those undergoing surgical procedures.
Quick answers
Who was awarded contract SPE2DR26F74ML?
SPE2DR26F74ML was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F74ML worth?
The government has obligated $10,443 on SPE2DR26F74ML.
Is contract SPE2DR26F74ML an order under another contract?
Yes. SPE2DR26F74ML is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74ML competed?
The extent of competition for SPE2DR26F74ML was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award